A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Humana Expands Medicare Advantage Network to Include Northeast Georgia Health System, Longstreet Clinic & Others Across Region

Northeast Georgia Health System (NGHS), a non-profit that cares for more than 1 million people across more than 18 counties, and leading health and well-being company Humana Inc. (NYSE: HUM) have signed an agreement that gives Humana Medicare Advantage members in-network access to medical facilities and physicians at Northeast Georgia Medical Center, Northeast Georgia Physicians Group, Georgia Heart Institute, Longstreet Clinic, Habersham Medical Center and more.

NGHS and members of our HP2 network with Health Partners have been a part of the Humana network for years, and we’re proud to now be a part of the Humana Medicare Advantage plans,” said Steve McNeilly, Chief Operating Officer of Population Health and Vice President of Managed Care for NGHS. “Bringing our patients access to hundreds of doctors at locations across the region is just one more way we’re improving the health of the community in all we do.”

The new agreement, which took effect Sept. 1, 2021, means current Humana Medicare Advantage HMO members now have in-network access to hundreds more physicians across Northeast Georgia. People with Medicare who select a Humana Medicare Advantage plan during the Medicare Annual Election Period, which runs from Oct. 15 to Dec. 7, 2021, will have access beginning Jan.1, 2022.

“We’re thrilled to add more quality medical facilities and health care practitioners like those at NGHS, Longstreet Clinic and others to our Humana network in Northeast Georgia,” said Matthew Moore, Humana Medicare President-Georgia and South Carolina. “We’re looking forward to working together to advance our mission to improve the health and well-being of the members we serve.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy